Related Experiment Video
Updated: Apr 24, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Ral GTPase down-regulation stabilizes and reactivates p53 to inhibit malignant transformation
Awet Tecleab1, Xiaolei Zhang2, Said M Sebti3
1From the Drug Discovery Department, H. Lee Moffitt Cancer Center and Research Institute and the Departments of Oncologic Sciences and Molecular Medicine, University of South Florida, Tampa, Florida 33612.
Abstract:
Ral GTPases are critical effectors of Ras, yet the molecular mechanism by which they induce malignant transformation is not well understood. In this study, we found the expression of K-Ras, RalB, and sometimes RalA, but not AKT1/2 and c-Raf, to be required for maintaining low levels of p53 in human cancer cells that harbor mutant K-Ras and wild-type p53. Down-regulation of K-Ras, RalB, and sometimes RalA increases p53 protein levels and results in a p53-dependent up-regulation of the expression of p21(WAF). K-Ras, RalA, and RalB depletion increases p53 stability as demonstrated by ataxia telangiectasia-mutated kinase activation, increased Ser-15 phosphorylation, and a significant (up to 6-fold) increase in p53 half-life. Furthermore, depletion of K-Ras and RalB inhibits anchorage-independent growth and invasion and interferes with cell cycle progression in a p53-dependent manner. Depletion of RalA inhibits invasion in a p53-dependent manner. Thus, expression of K-Ras and RalB and possibly RalA proteins is critical for maintaining low levels of p53, and down-regulation of these GTPases reactivates p53 by significantly enhancing its stability, and this contributes to suppression of malignant transformation.
Insights
Ras pathway proteins K-Ras and Ral GTPases (RalA, RalB) maintain low p53 levels in cancer. Their depletion stabilizes p53, suppressing malignant transformation and tumor growth.
Area of Science:
- Molecular biology
- Cancer research
- Cell signaling
Background:
- Ras GTPases are crucial for cell growth and cancer.
- The precise role of Ral GTPases in malignant transformation is unclear.
- Understanding K-Ras and Ral GTPase regulation of p53 is vital for cancer therapy.
Purpose of the Study:
- Investigate the role of K-Ras and Ral GTPases in regulating p53 levels in cancer cells.
- Determine the impact of K-Ras and Ral GTPase depletion on p53 stability and function.
- Assess the effect of K-Ras and Ral GTPase down-regulation on cancer cell malignant behaviors.
Main Methods:
- Analyzed expression of K-Ras, RalA, RalB, AKT1/2, and c-Raf in human cancer cells.
- Utilized gene depletion techniques (e.g., siRNA) to reduce K-Ras, RalA, and RalB levels.
- Measured p53 protein levels, p53 stability (via ATM kinase activation, phosphorylation, and half-life), and p21(WAF) expression.
- Assessed anchorage-independent growth, invasion, and cell cycle progression.
Main Results:
- K-Ras, RalB, and RalA expression is required to maintain low p53 levels in mutant K-Ras cancer cells.
- Depletion of K-Ras, RalB, or RalA increases p53 protein levels and stability, enhancing p21(WAF) expression.
- K-Ras and RalB depletion inhibits anchorage-independent growth and invasion, while RalA depletion inhibits invasion, all in a p53-dependent manner.
- p53 stability was significantly increased (up to 6-fold) upon GTPase depletion.
Conclusions:
- K-Ras and RalB, and possibly RalA, are critical for suppressing p53 activity in cancer.
- Down-regulating these GTPases reactivates p53 by enhancing its stability, thereby suppressing malignant transformation.
- Targeting K-Ras and Ral GTPases may offer a therapeutic strategy for reactivating p53 and inhibiting cancer progression.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
GTPases and their Regulation
Large G-proteins,...
GTPases and their Regulation

